Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prevalence of the JAK2 V617F Mutation in Patients with Non-Cardioembolic Stroke.

Journal of atherosclerosis and thrombosis - 1 Mar 2026

Oyama Naoki, Okazaki Tomoko, Miura Hitoshi, Doyu Keito, Iwamoto Takanori, Matsuzaki Jo, Yagita Yoshiki

Abstract excerpt

AIM: This study attempted to clarify the prevalence and clinical characteristics of Janus kinase 2 V617F (JAK2) gene mutations in patients with cerebrovascular diseases. METHODS: We prospectively enrolled patients who were admitted to or referred to our department with cerebrovascular disease due to suspected major cerebral artery disease or small-vessel occlusion within 30 days of onset between January 1, 2021,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Aged, 80 and over
Share to Janus Kinase 2

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Prevalence

Share to Prognosis

Share to Risk Factors

Share to Stroke

Source

Open in PubMed Open full text

Identifiers

PMID: 41139495
DOI: 10.5551/jat.65896
PMCID: PMC12979947

Genes

JAK2

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prevalence of the JAK2 V617F Mutation in Patients with Non-Cardioembolic Stroke.PMID 41139495Read ↗

Prevalence and Clinical Characteristics of Patients with Ischemic Stroke with <i>JAK2</i> V617F Mutation and Normal Blood CountsSemantic proximity Read ↗

JAK2 V617F Mutation and Large Cerebral Artery Disease in Patients with Myeloproliferative Neoplasms.Semantic proximity Read ↗

JAK2 pathogenic variants in ischemic stroke: low prevalence and pre-screening model.Semantic proximity Read ↗

JAK2V617F mutation is highly prevalent in patients with ischemic stroke: a case-control study.Semantic proximity Read ↗

Essential Thrombocythemia and Ischemic Stroke: A Case Series of Five JAK2-Positive PatientsSemantic proximity Read ↗

Essential Thrombocythemia and Ischemic Stroke: A Case Series of Five JAK2-Positive Patients.Semantic proximity Read ↗

Cerebral venous sinus thrombosis associated with JAK2 V617F mutation-related pre-primary myelofibrosis: a case report and literature review.Semantic proximity Read ↗

Implications of Janus Kinase 2 Mutation in Embolic Stroke of Unknown Source.Semantic proximity Read ↗

Proposal for the Ischemic Stroke Phenotyping System 2025: ISPS25.Semantic proximity Read ↗

A case of ischemic stroke with hemorrhagic transformation associated with essential thrombocythemia and JAK-2 V617F mutation.Semantic proximity Read ↗

Recurrent Stroke with Rapid Development of Intracranial Artery Stenosis and Subsequent Successful Mechanical Thrombectomy in Essential Thrombocythemia.Semantic proximity Read ↗

Stroke risk, phenotypes, and death in COVID-19: Systematic review and newly reported cases.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.